These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28435226)

  • 1. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
    Lin T; Gong L
    Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
    Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
    Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
    Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
    Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.
    Rho CR; Choi JS; Seo M; Lee SK; Joo CK
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5871-9. PubMed ID: 26348636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
    Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.
    Hos D; Koch KR; Bucher F; Bock F; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6133-42. PubMed ID: 23970469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal Collagen Cross-Linking With Riboflavin and UVA Regulates Hemangiogenesis and Lymphangiogenesis in Rats.
    Zhu Y; Li L; Reinach PS; Li Y; Ge C; Qu J; Chen W
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3702-3712. PubMed ID: 30029257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
    Lipp M; Bucher F; Parthasarathy A; Hos D; Onderka J; Cursiefen C; Bock F
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):943-9. PubMed ID: 24728466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
    Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
    Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo.
    Ischenko I; Seeliger H; Camaj P; Kleespies A; Guba M; Eichhorn ME; Jauch KW; Bruns CJ
    Curr Cancer Drug Targets; 2010 Aug; 10(5):546-53. PubMed ID: 20370688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
    García-Caballero M; Blacher S; Paupert J; Quesada AR; Medina MA; Noël A
    Br J Pharmacol; 2016 Jun; 173(12):1966-87. PubMed ID: 27018653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
    Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
    Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
    Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
    Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
    Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin Alpha-9 Mediates Lymphatic Valve Formation in Corneal Lymphangiogenesis.
    Altiok E; Ecoiffier T; Sessa R; Yuen D; Grimaldo S; Tran C; Li D; Rosner M; Lee N; Uede T; Chen L
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6313-9. PubMed ID: 26431485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.
    Hos D; Saban DR; Bock F; Regenfuss B; Onderka J; Masli S; Cursiefen C
    Arch Ophthalmol; 2011 Apr; 129(4):445-52. PubMed ID: 21482870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.